Racial disparity in the prevalence of BCL-2 expression and associations with breast cancer survival in the Breast Cancer Care in Chicago study

被引：0

作者：

Alim, Jibril M. ^{[1
]}

Hoskins, Kent ^{[1
]}

Mahmoud, Abeer M. ^{[1
]}

Macias, Virgilia ^{[1
]}

Kadjascy-Balla, Andre ^{[1
]}

Rauscher, Garth H. ^{[1
]}

机构：

[1] Univ Illinois, Chicago, IL USA

来源：

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | 2020年 / 29卷 / 06期

关键词：

D O I：

10.1158/1538-7755.DISP18-C098

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

C098

引用

页数：2

共 50 条

[21] Bcl-2 protein expression in breast cancer and its relationship to prognosis [J].

Yamaguchi, A ;

Maehara, M ;

Goi, T ;

Katayama, K ;

Hirose, K ;

Nakagawara, G .

INTERNATIONAL JOURNAL OF ONCOLOGY, 1997, 10 (03) :581-584

[22] Bcl-2 expression in cell lines breast cancer and death program [J].

Janaghard, Mohsen Sedaghat ;

Soleimani, Shahrzad ;

Movafagh, Abolfazl ;

Motallebi, Marzieh ;

Mousavi, Seyede Amenh ;

Moghadam, Ali Akbar Saffar ;

Moghadam, Vahid Erfani ;

Khosravi, Ayoob ;

Mirzaei, Hamid Reza ;

Mousavi, Seyed Ali Reza ;

Aziziaram, Zahra ;

Sun, Chenghui .

CELLULAR AND MOLECULAR BIOLOGY, 2023, 69 (14) :277-285

[23] Targeting the Pro-survival Protein BCL-2 to Prevent Breast Cancer [J].

Young, Adelaide ;

Bu, Wen ;

Jiang, Weiyu ;

Ku, Amy ;

Kapali, Jyoti ;

Dhamne, Sagar ;

Qin, Lan ;

Hilsenbeck, Susan G. ;

Du, Yi-Chieh Nancy ;

Li, Yi .

CANCER PREVENTION RESEARCH, 2022, 15 (01) :3-10

[24] An Immunohistochemistry Study of Tissue Bcl-2 Expression and Its Serum Levels in Breast Cancer Patients [J].

Alireza, Andalib ;

Raheleh, Shokohi ;

Abbass, Rezaei ;

Mojgan, Mokhtari ;

Mohamadreza, Mohageri ;

Gholamreza, Mohageri ;

Shadi, Babazadeh .

RECENT ADVANCES IN CLINICAL ONCOLOGY, 2008, 1138 :114-120

[25] Prognostic value of bcl-2 expression among women with breast cancer in Libya [J].

Ermiah, Eramah ;

Buhmeida, Abdelbaset ;

Khaled, Ben Romdhane ;

Abdalla, Fathi ;

Salem, Nada ;

Pyrhonen, Seppo ;

Collan, Yrjo .

TUMOR BIOLOGY, 2013, 34 (03) :1569-1578

[26] Prognostic significance of BCL-2 expression in triple negative breast cancer (TNBC) [J].

Srinivasalu, V. K. ;

Susan, A. ;

Jose, W. M. ;

Philip, A. ;

Nambiar, A. ;

Pavithran, K. .

ANNALS OF ONCOLOGY, 2019, 30

[27] Expression of Bax in relation to Bcl-2 and other predictive parameters in breast cancer [J].

Binder, C ;

Marx, D ;

Binder, L ;

Schauer, A ;

Hiddemann, W .

ANNALS OF ONCOLOGY, 1996, 7 (02) :129-133

[28] Clinical significance of bcl-2 gene expression in human breast cancer tissues [J].

Kobayashi, S ;

Iwase, H ;

Ito, Y ;

Yamashita, H ;

Iwata, H ;

Yamashita, T ;

Ito, K ;

Toyama, T ;

Nakamura, T ;

Masaoka, A .

BREAST CANCER RESEARCH AND TREATMENT, 1997, 42 (02) :173-181

[29] Bcl-2 as marker of tamoxifen failure in breast cancer [J].

Larsen, M. Skaarup ;

Laenkholm, A. V. ;

Knoop, A. ;

Lykkesfeldt, A. E. ;

Rasmussen, B. Bruun .

APMIS, 2010, 118 :16-17

[30] Bcl-2 antigen expression in luminal A and triple-negative breast cancer [J].

Escorcio-Dourado, Carla Solange ;

Martins, Luana Mota ;

Simplicio-Revoredo, Camila Maria ;

Sampaio, Fabiane Araujo ;

Tavares, Cleciton Braga ;

da Silva-Sampaio, Joao Paulo ;

Borges, Umbelina Soares ;

Alves-Ribeiro, Francisco Adelton ;

Lopes-Costa, Pedro Vitor ;

Lima-Dourado, Jose Charles ;

da Silva, Benedito Borges .

MEDICAL ONCOLOGY, 2017, 34 (09)

← 1 2 3 4 5 →